| Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes EA Rakha, SE Elsheikh, MA Aleskandarany, HO Habashi, AR Green, ... Clinical cancer research 15 (7), 2302-2310, 2009 | 689 | 2009 |
| Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen HO Habashy, DG Powe, CM Staka, EA Rakha, G Ball, AR Green, ... Breast cancer research and treatment 119, 283-293, 2010 | 284 | 2010 |
| CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome S Elsheikh, AR Green, MA Aleskandarany, M Grainge, CE Paish, ... Breast cancer research and treatment 109, 325-335, 2008 | 185 | 2008 |
| Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer MA Aleskandarany, AR Green, AA Benhasouna, FF Barros, K Neal, ... Breast Cancer Research 14, 1-11, 2012 | 172 | 2012 |
| MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups MA Aleskandarany, EA Rakha, RD Macmillan, DG Powe, IO Ellis, ... Breast cancer research and treatment 127, 591-599, 2011 | 141 | 2011 |
| MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours AR Green, MA Aleskandarany, D Agarwal, S Elsheikh, CC Nolan, ... British journal of cancer 114 (8), 917-928, 2016 | 140 | 2016 |
| The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast EA Rakha, M Aleskandarany, ME El-Sayed, RW Blamey, CW Elston, ... European Journal of Cancer 45 (10), 1780-1787, 2009 | 130 | 2009 |
| A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer MAH Ahmed, MA Aleskandarany, EA Rakha, RZA Moustafa, ... Breast cancer research and treatment 133, 979-995, 2012 | 124 | 2012 |
| PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis MA Aleskandarany, EA Rakha, MAH Ahmed, DG Powe, EC Paish, ... Breast cancer research and treatment 122, 45-53, 2010 | 116 | 2010 |
| Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis MA Aleskandarany, R Abduljabbar, I Ashankyty, A Elmouna, D Jerjees, ... Breast cancer research and treatment 159, 215-227, 2016 | 113 | 2016 |
| Tumour heterogeneity of breast cancer: from morphology to personalised medicine MA Aleskandarany, ME Vandenberghe, C Marchiò, IO Ellis, A Sapino, ... Pathobiology 85 (1-2), 23-34, 2018 | 105 | 2018 |
| Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance M Althobiti, MA Aleskandarany, C Joseph, M Toss, N Mongan, ... Histopathology 73 (6), 887-896, 2018 | 95 | 2018 |
| MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer ML Craze, H Cheung, N Jewa, NDM Coimbra, D Soria, R El-Ansari, ... British journal of cancer 118 (2), 258-265, 2018 | 94 | 2018 |
| Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT–YB1–MDR1 signaling pathway D Mo, H Fang, K Niu, J Liu, M Wu, S Li, T Zhu, MA Aleskandarany, A Arora, ... Cancer Research 76 (10), 3057-3066, 2016 | 93 | 2016 |
| FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer HO Habashy, EA Rakha, M Aleskandarany, MAH Ahmed, AR Green, ... Breast cancer research and treatment 129, 11-21, 2011 | 89 | 2011 |
| Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer A Albasri, S Al-Ghamdi, W Fadhil, M Aleskandarany, YC Liao, D Jackson, ... Oncogene 30 (26), 2997-3002, 2011 | 89 | 2011 |
| Breast cancer intratumour heterogeneity: current status and clinical implications C Joseph, A Papadaki, M Althobiti, M Alsaleem, MA Aleskandarany, ... Histopathology 73 (5), 717-731, 2018 | 86 | 2018 |
| Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study MA Aleskandarany, OH Negm, AR Green, MAH Ahmed, CC Nolan, ... Breast cancer research and treatment 145, 339-348, 2014 | 84 | 2014 |
| Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ I Miligy, P Mohan, A Gaber, MA Aleskandarany, CC Nolan, ... Histopathology 71 (2), 258-268, 2017 | 83 | 2017 |
| Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer MA Aleskandarany, EA Rakha, MA Ahmed, DG Powe, IO Ellis, AR Green Breast cancer research and treatment 127, 407-416, 2011 | 82 | 2011 |
Graham BallChief Scientific Officer Intelligent Omics LtdBestätigte E-Mail-Adresse bei ntu.ac.uk
